This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. slipped 3.4% to $7.42 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.9% to 22,886.07 and the Dow Jones Industrial Average rising 0.5% to 49,625.97.
Corbus Pharmaceuticals Holdings Inc. closed 63.9% below its 52-week high of $20.56, which the company achieved on October 20th.
The stock demonstrated a mixed performance when compared to some of its peers, as Vanda Pharmaceuticals Inc. fell 5.6% to $5.76, Fortress Biotech Inc. fell 3.4% to $3.36, and Viking Therapeutics Inc. fell 0.23% to $31.03.
Trading volume totaled 101,664, compared to the 50-day average of 291,416.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
February 20, 2026 16:34 ET (21:34 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.